Cargando…
Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
Well-differentiated pancreatic neuroendocrine tumors are increasingly diagnosed neoplasms. For localized disease, surgery is the first-line therapy and is curative in most cases. However, although recurrence is a rare event, it can still occur up to 10 years from surgery, worsening the prognosis. Ma...
Autores principales: | Pulvirenti, Alessandra, Pea, Antonio, Chang, David K., Jamieson, Nigel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419466/ https://www.ncbi.nlm.nih.gov/pubmed/32850899 http://dx.doi.org/10.3389/fmed.2020.00385 |
Ejemplares similares
-
Role of Pre-operative Inflammatory Markers as Predictors of Lymph Node Positivity and Disease Recurrence in Well-Differentiated Pancreatic Neuroendocrine Tumours: Pancreas2000 Research and Educational Program (Course 9)
por: Tanno, Lulu, et al.
Publicado: (2020) -
Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study
por: Zhang, Pan, et al.
Publicado: (2019) -
Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors
por: Tan, Qing-quan, et al.
Publicado: (2020) -
Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020) -
Two well-differentiated pancreatic neuroendocrine tumor mouse models
por: Wong, Chung, et al.
Publicado: (2019)